Talar Telvizian

Evaluation of an AI-based digital pathology tool for breast cancer recurrence risk

Hormone receptor-positive (HR+) breast cancer is the most common type among women in the United States. Multigene assays such as Oncotype DX (ODX) assess recurrence risk and chemotherapy benefit but are costly and time-consuming. This exploratory study evaluates the AI-powered Pr...